I keep going back to that 2/15/2024 Update from Dr
Post# of 7872
MANUFACTURING
The Company, working with its Chinese manufacturer, recently redesigned the manufacturing process to increase the reliability and shelf life of its current OTC product. The Company also did a proof-of-concept production run of its newly designed RecoveryRx product that is 50% more powerful and has a larger antenna thereby increasing the size of the surgical incision that can be treated. The plan is to test market these devices in the near future.
Why would BIEL, struggling to keep the lights on, spend money to "redesign the manufacturing process" of the ActiPatch unless it was something critical, like a condition of a deal.
Hopefully we get enlightened before the end of the year.